DR. JOGITHA

Dr. SANDRA CHANDRAMOULI

Abstract

Methods: In this prospective study in patients with acute acquired concomitant esotropia from November 2020 to March 2021. All patients were advised Brain MRI scan prior to treatment. Pre and post injection angle of deviation and stereopsis were evaluated. Any corrective squint surgery in recurrence patients later were evaluated.Results: A total of 15 patients were treated with botulinum toxin. Age group of 5 to 25 years were included in this study, with mean average age of 13.4 years. After botulinum injections, the success rate was 66.66% (10/15), and the recurrence rate was 33.33% (5/15). Ten patients were treated successfully. Five patents with recurrence were advised corrective surgery.Conclusion: Botulinum toxin has a definite role in the treatment of patients with acute-onset esotropia. It may avoid the need for squint surgery. Its a safe and easy procedure of treatment. Early post operative recovery and patient comfort add to the merits of this procedure.

Full Text